Wire Stories
EpimAb Biotherapeutics Strengthens Scientific Advisory Board with Addition of Professor Mark Smyth
SHANGHAI, China–(BUSINESS WIRE)–EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutical company specializing in bispecific antibodies, today announced the appointment of Professor Mark Smyth to...